Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 391984, 9 pages
http://dx.doi.org/10.1155/2013/391984
Review Article

Remarkable Role of Indoleamine 2,3-Dioxygenase and Tryptophan Metabolites in Infectious Diseases: Potential Role in Macrophage-Mediated Inflammatory Diseases

1Human Health Sciences, Graduate School of Medicine and Faculty of Medicine, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-Ku, Kyoto 606-8507, Japan
2Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie, Tsu 510-0293, Japan

Received 12 October 2012; Revised 28 December 2012; Accepted 3 January 2013

Academic Editor: Chiou-Feng Lin

Copyright © 2013 Yuki Murakami et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [32 citations]

The following is the list of published articles that have cited the current article.

  • Györgyi Műzes, Ferenc Sipos, István Fűri, Miklós Constantinovits, Sándor Spisák, Barnabás Wichmann, Gábor Valcz, Zsolt Tulassay, and Béla Molnár, “Preconditioning with Intravenous Colitic Cell-Free DNA Prevents DSS-Colitis by Altering TLR9-Associated Gene Expression Profile,” Digestive Diseases and Sciences, 2014. View at Publisher · View at Google Scholar
  • Wan-li Liu, Yue-hao Lin, Han Xiao, Shan Xing, Hao Chen, Pei-dong Chi, and Ge Zhang, “Epstein-Barr Virus Infection Induces Indoleamine 2,3-Dioxygenase Expression in Human Monocyte-Derived Macrophages through p38/Mitogen-Activated Protein Kinase and NF-kappa B Pathways: Impairment in T Cell Functions,” Journal of Virology, vol. 88, no. 12, pp. 6660–6671, 2014. View at Publisher · View at Google Scholar
  • Ayako Taguchi, Masayuki Niwa, Masato Hoshi, Kuniaki Saito, Teruaki Masutani, Kenji Hisamatsu, Kazuhiro Kobayashi, Yuichiro Hatano, Hiroyuki Tomita, and Akira Hara, “Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis,” Neuroscience Letters, vol. 564, pp. 120–125, 2014. View at Publisher · View at Google Scholar
  • Deok Jeong, Young-Su Yi, Gi-Ho Sung, Woo Seok Yang, Jae Gwang Park, Keejung Yoon, Deok Hyo Yoon, Changsik Song, Yunmi Lee, Jong-Hoon Kim, Man Hee Rhee, Tae Woong Kim, and Jae Youl Cho, “Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract,” Journal of Ethnopharmacology, 2014. View at Publisher · View at Google Scholar
  • Tiziana Larussa, Isabella Leone, Evelina Suraci, Immacolata Nazionale, Teresa Procopio, Francesco Conforti, Ludovico Abenavoli, Marta L. Hribal, Maria Imeneo, and Francesco Luzza, “ Enhanced Expression of Indoleamine 2,3-Dioxygenase in Helicobacter pylori -Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production ,” Helicobacter, 2014. View at Publisher · View at Google Scholar
  • Yangzom D. Bhutia, Ellappan Babu, and Vadivel Ganapathy, “Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells,” Biochimica et Biophysica Acta (BBA) - Biomembranes, 2014. View at Publisher · View at Google Scholar
  • Andrea C. Love, Ira Schwartz, and Mary M. Petzke, “Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential,” Journal Of Leukocyte Biology, vol. 97, no. 2, pp. 379–390, 2015. View at Publisher · View at Google Scholar
  • Maciej J. Pelak, Miroslaw Snietura, Dariusz Lange, Barbara Nikiel, and Katarzyna M. Pecka, “THE PROGNOSTIC SIGNIFICANCE OF INDOLEAMINE-2,3-DIOXYGENASE AND THE RECEPTORS FOR TRANSFORMING GROWTH FACTOR B AND INTERFERON Gamma IN METASTATIC LYMPH,” Polish Journal Of Pathology, vol. 66, no. 4, pp. 376–382, 2015. View at Publisher · View at Google Scholar
  • Theofanis Karageorgas, Sofia Fragioudaki, Adrianos Nezos, Dimitrios Karaiskos, Haralampos M. Moutsopoulos, and Clio P. Mavragani, “Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations,” Arthritis Care & Research, vol. 68, no. 1, pp. 123–131, 2015. View at Publisher · View at Google Scholar
  • Silvia Kathrin Eller, and Walter Däubener, “Role of Kynurenine Pathway in Infections,” Targeting the Broadly Pathogenic Kynurenine Pathway, pp. 179–190, 2015. View at Publisher · View at Google Scholar
  • Yuki Murakami, Hiroyasu Ito, and Kuniaki Saito, “The Role of L-Tryptophan Kynurenine Pathway Metabolism in Various Infectious Diseases: Focus on Indoleamine 2,3-Dioxygenase 1,” Tryptophan Metabolism: Implications for Biological Processes, Health and Disease, pp. 95–120, 2015. View at Publisher · View at Google Scholar
  • Petros Xe Mouratidis, and Andrew Jt George, “Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells.,” Journal of inflammation research, vol. 8, pp. 97–106, 2015. View at Publisher · View at Google Scholar
  • Paul B. Larkin, Korrapati V. Sathyasaikumar, Francesca M. Notarangelo, Hiroshi Funakoshi, Toshikazu Nakamura, Robert Schwarcz, and Paul J. Muchowski, “Tryptophan 2,3-Dioxygenase and Indoleamine 2,3-Dioxygenase 1 Make Separate, Tissue-Specific Contributions to Basal and Inflammation-Induced Kynurenine Pathway Metabolism in Mice,” Biochimica et Biophysica Acta (BBA) - General Subjects, 2016. View at Publisher · View at Google Scholar
  • Jun Hee Lee, Jung Min Ryu, Yong-Seok Han, Mohammad Farid Zia, Hyog Young Kwon, Hyunjin Noh, Ho Jae Han, and Sang Hun Lee, “Fucoidan improves bioactivity and vasculogenic potential of mesenchymal stem cells in murine hind limb ischemia associated with chronic kidney disease,” Journal of Molecular and Cellular Cardiology, 2016. View at Publisher · View at Google Scholar
  • Cara C Schafer, Yong Wang, Kenneth P Hough, Anandi Sawant, Stefan C Grant, Victor J Thannickal, Jaroslaw Zmijewski, Selvarangan Ponnazhagan, and Jessy S Deshane, “Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.,” Oncotarget, vol. 7, no. 46, pp. 75407–75424, 2016. View at Publisher · View at Google Scholar
  • Alexandra K. Brooks, Marcus A. Lawson, Jennifer L. Rytych, Kevin C. Yu, Tiffany M. Janda, Andrew J. Steelman, and Robert H. McCusker, “Immunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the Kynurenine Pathway in the Mouse Hippocampus,” Frontiers in Immunology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Josephine F Trott, Katie Anderson, Ashley Graef, Aaron L Sarver, Jaime F Modiano, Robert H Weiss, Jeffrey Kim, Omran Abu Aboud, Hiromi Wettersten, Benjamin Stewart, Grace Berryhill, Francisco Uzal, Russell C Hovey, and Ching-Hsien Chen, “Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.,” Oncotarget, vol. 7, no. 41, pp. 66540–66557, 2016. View at Publisher · View at Google Scholar
  • Francesco Antonio Greco, Alice Coletti, Emidio Camaioni, Andrea Carotti, Maura Marinozzi, Antimo Gioiello, and Antonio Macchiarulo, “The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities,” Future Medicinal Chemistry, vol. 8, no. 1, pp. 39–54, 2016. View at Publisher · View at Google Scholar
  • Gerwyn Morris, Andre F. Carvalho, George Anderson, Piotr Galecki, and Michael Maes, “The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders,” Current Pharmaceutical Design, vol. 22, no. 8, pp. 963–977, 2016. View at Publisher · View at Google Scholar
  • Lionella Palego, Laura Betti, Alessandra Rossi, and Gino Giannaccini, “Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans,” Journal of Amino Acids, vol. 2016, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Peter M. Schmid, Abdellatif Bouazzaoui, Karin Schmid, Christoph Birner, Christian Schach, Lars S. Maier, Ernst Holler, and Dierk H. Endemann, “Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation,” Cell Transplantation, vol. 26, no. 8, pp. 1428–1440, 2017. View at Publisher · View at Google Scholar
  • Peter M. Schmid, Abdellatif Bouazzaoui, Karin Schmid, Christoph M. Birner, Christian Schach, Lars S. Maier, Ernst Holler, and Dierk H. Endemann, “Vascular Alterations in a Murine Model of Acute Graft-Versus-Host Disease Are Associated with Decreased Serum Levels of Adiponectin and an Increased Activity and Vascular Expression of Indoleamine 2,3-Dioxygenase,” Cell Transplantation, vol. 25, no. 11, pp. 2051–2062, 2017. View at Publisher · View at Google Scholar
  • Marco Gelpi, Hans J. Hartling, Per M. Ueland, Henrik Ullum, Marius Trøseid, and Susanne D. Nielsen, “Tryptophan catabolism and immune activation in primary and chronic HIV infection,” BMC Infectious Diseases, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Mark R. Nicolls, and Norbert F. Voelkel, “The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 195, no. 10, pp. 1292–1299, 2017. View at Publisher · View at Google Scholar
  • Danuta Gutowska-Owsiak, and Graham S. Ogg, “Therapeutic vaccines for allergic disease,” npj Vaccines, vol. 2, no. 1, 2017. View at Publisher · View at Google Scholar
  • Alexandra K. Brooks, Tiffany M. Janda, Marcus A. Lawson, Jennifer L. Rytych, Robin A. Smith, Cecilia Ocampo-Solis, and Robert H. McCusker, “Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases,” Brain, Behavior, and Immunity, vol. 62, pp. 219–229, 2017. View at Publisher · View at Google Scholar
  • Yong-Ku Kim, and Eunsoo Won, “The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder,” Behavioural Brain Research, 2017. View at Publisher · View at Google Scholar
  • Bodil Bjørndal, Inge Bruheim, Vegard Lysne, Marie S. Ramsvik, Per M. Ueland, Jan E. Nordrehaug, Ottar K. Nygård, and Rolf K. Berge, “Plasma choline, homocysteine and vitamin status in healthy adults supplemented with krill oil: a pilot study,” Scandinavian Journal of Clinical and Laboratory Investigation, pp. 1–6, 2018. View at Publisher · View at Google Scholar
  • Nobuki Kuwano, Takahiro A. Kato, Daiki Setoyama, Mina Sato-Kasai, Norihiro Shimokawa, Kohei Hayakawa, Masahiro Ohgidani, Noriaki Sagata, Hiroaki Kubo, Junji Kishimoto, Dongchon Kang, and Shigenobu Kanba, “Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: an exploratory pilot case-control study,” Journal of Affective Disorders, 2018. View at Publisher · View at Google Scholar
  • Claudia J. Stocks, Mark A. Schembri, Matthew J. Sweet, and Ronan Kapetanovic, “For when bacterial infections persist: Toll-like receptor-inducible direct antimicrobial pathways in macrophages,” Journal of Leukocyte Biology, 2018. View at Publisher · View at Google Scholar
  • Adrianos Nezos, Maria-Eleutheria Evangelopoulos, and Clio P. Mavragani, “Genetic contributors and soluble mediators in prediction of autoimmune comorbidity,” Journal of Autoimmunity, pp. 102317, 2019. View at Publisher · View at Google Scholar
  • Arghya Ray, Yan Song, Ting Du, Yu-Tzu Tai, Dharminder Chauhan, and Kenneth C. Anderson, “Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma,” Leukemia, 2019. View at Publisher · View at Google Scholar